Endocrinology Watch 13 – Elinzanetant for vasomotor symptoms from endocrine therapy for breast cancer

Cardiology Watch 23 – post-ACS residual CV risk: what’s the approach to TG in 2025?

Multiple Sclerosis Research Review Issue 88

Eye Health Research Review Issue 74

Sleep Research Review Issue 15

Dermatology Research Review Issue 120

Multiple Myeloma Research Review, Issue 67

HIV Nurses Research Review Issue 3

EHA Congress 2025 Conference Review focus on Myelofibrosis

Gastroenterology Research Review, Issue 126